Load reduction in live PRRS vaccines using oil and polymer adjuvants
Sebastien Deville1, Juliette Ben Arous1, Ghislaine Ionkoff1
1SEPPIC, 22 Terrasse Bellini, Paris La Défense, 92806 Puteaux Cedex, France.
Adjuvants enhance the efficacy of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) live vaccines. Adding polymer or oil adjuvants to PRRSV vaccines boosted protection, even with reduced antigen load.
Area of Science:
- Veterinary immunology
- Vaccinology
- Animal health
Background:
- Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) live vaccines are crucial in swine farming.
- Current PRRSV vaccines are typically unadjuvanted, raising questions about safety and antigen load.
- Reducing antigen load while maintaining vaccine efficacy is a key objective for safer PRRSV vaccines.
Purpose of the Study:
- To investigate the impact of polymer or oil adjuvants on the efficacy of PRRSV live vaccines.
- To determine if adjuvants can maintain vaccine protection with a reduced antigen load.
- To assess if adjuvants enhance the protective immune response against PRRSV challenge.
Main Methods:
- Live PRRSV vaccine formulations were prepared with polymer or oil adjuvants.
- Vaccinated pigs were challenged with PRRSV to assess protection.
- Humoral immune responses, including antibody titers, were measured.
- Protection levels were compared between adjuvanted and non-adjuvanted vaccine groups.
Main Results:
- Adjuvanted PRRSV vaccines significantly enhanced protection against PRRSV challenge compared to non-adjuvanted controls.
- Adjuvanted vaccines with 50% antigen load provided protection equivalent to non-adjuvanted vaccines with full antigen load.
- Despite lower antibody titers in adjuvanted groups, protection was maintained or improved.
Conclusions:
- The addition of polymer or oil adjuvants can significantly improve the protective efficacy of PRRSV live vaccines.
- Adjuvants enable a reduction in antigen load without compromising vaccine effectiveness.
- Adjuvants represent a viable strategy to enhance PRRSV vaccine performance and potentially improve safety profiles.
More Related Videos
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
06:02Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
Published on: February 23, 2024
